OBJECTIVES

To describe the current state of non-ICU high flow nasal cannula (HFNC) protocols at children’s hospitals and explore associations between HFNC protocol type and utilization outcomes.

METHODS

We performed a cross-sectional study of the Pediatric Health Information Systems (PHIS) database. First, we designed a survey with the purpose of classifying HFNC protocols used at hospitals currently contributing data to PHIS. Next, we categorized hospitals based on their current HFNC protocol (ICU only, age-based non-ICU, or weight-based non-ICU). Finally, using the PHIS database, we compared hospital characteristics and patient-level bronchiolitis outcomes by HFNC protocol group.

RESULTS

We received survey responses from 36 of 44 (82%) hospitals contributing data to PHIS in 2021. During the time period studied, there was a steady increase in adoption of non-ICU HFNC protocols, with 71% of responding children’s hospitals reporting non-ICU HFNC protocols in 2021 compared with 11% before 2010. No differences in hospital characteristics were observed between ICU-only hospitals, age-based hospitals, or weight-based hospitals. Age-based hospitals had the highest proportion of bronchiolitis patients treated in the ICU (36.1%), whereas weight-based hospitals had the lowest proportion of patients treated in the ICU (21.0%, P < .001). Length of stay was longer at age-based hospitals (2.9 days) as compared with weight-based and ICU-only hospitals (1.9 days, P < .001).

CONCLUSIONS

Most children’s hospitals have adopted non-ICU HFNC protocols for patients with bronchiolitis, the majority of which are now utilizing weight-based maximum flow rates. Weight-based HFNC protocols were associated with decreased ICU utilization compared with age-based HFNC protocols.

The use of high flow nasal cannula (HFNC) as a respiratory support modality in children with bronchiolitis has risen dramatically.14  Though the full extent of its use has not been characterized, 2 single-institution studies found year-over-year increases in HFNC use in patients with bronchiolitis since HFNC adoption, with 1 site using it in up to 70% of hospitalized patients with bronchiolitis in 2017.3,58  Furthermore, the protocolized use of HFNC in non-ICU settings has become common, with 1 survey conducted in 2017 finding that 37 of 77 (48%) responding sites used HFNC on the pediatric wards.2 

Early protocols for non-ICU use of HFNC used age-based (eg, 8 L of flow for children under 12 months of age) flow rates and have been associated with increased ICU utilization.1,9  More recently, there has been a shift toward the use of weight-based (eg, 2 L of flow per kilogram of body weight) flow rates, which have been studied in several recent randomized trials. However, these trials have not demonstrated that weight-based HFNC decreases ICU utilization or hospital length of stay (LOS).10,11 

The extent to which weight-based flow rates have since been adopted in non-ICU HFNC protocols and whether they offer clinical benefits over age-based protocols has not been fully characterized. Our primary objective was to describe the current state of non-ICU HFNC protocols at children’s hospitals. Our secondary objective was to explore associations between HFNC protocol type and utilization outcomes.

We conducted a cross-sectional database study. We augmented our database study with a brief survey to obtain key details not otherwise available in the database.

We designed a survey with the purpose of classifying HFNC protocol use at all hospitals contributing to the Pediatric Health Information Systems (PHIS) database in 2021. We piloted the survey by e-mailing contacts at 4 hospitals and made changes to the survey based on feedback. Contacts at each hospital were identified from 2 sources: (1) our prior national HFNC survey and (2) membership in the American Academy of Pediatrics sponsored HFNC improvement collaborative, “High Flow Interventions to Facilitate Less Overuse.”9,12  The survey was administered electronically and included branching logic to first determine if their hospital allowed HFNC initiation outside the ICU and then to determine key dates of protocol initiation and transition. After this, survey questions on specific protocol features, such as inclusion and exclusion criteria, maximum flow rates, and fraction of inspired oxygen allowed, targeted the hospital’s current protocol.

Hospitals were categorized into 3 groups based on their current protocol: ICU only, age-based, and weight-based. ICU-only hospitals were defined as hospitals for which any HFNC use for bronchiolitis required at least initial care in the ICU. Age-based hospitals were defined as hospitals that allowed initial HFNC use on the non-ICU ward and targeted flow rates based on patient age. Weight-based hospitals were defined as hospitals that allowed initial HFNC use on the non-ICU ward and targeted flow rates based on patient weight.

We obtained hospital characteristics and patient outcomes from the PHIS database. The PHIS database includes patient-level data from children’s hospitals in the United States, including patient demographic characteristics, procedure codes, and discharge diagnosis codes.

Patients were included if they had an International Classification of Diseases 10 (ICD-10) code consistent with bronchiolitis in any diagnostic position.13,14  We included 4 hospital-level utilization outcome variables, including the proportion of patients treated in the ICU, total hospital LOS, the proportion treated with noninvasive positive pressure ventilation (NIPPV), which included continuous positive airway pressure and bilevel positive airway pressure, and the proportion treated with invasive mechanical ventilation (IMV). Patients were classified as having received NIPPV if they had an ICD-10 procedure code for NIPPV and having received IMV if they had a procedure or supply code for mechanical ventilation and a pharmacy charge code for a neuromuscular blocking agent based on previously published definitions.1416  A crosswalk available from the Centers for Medicare and Medicaid Services was used to convert previously published definitions that used ICD-9 codes to ICD-10 codes. A reliable measure of HFNC exposure is not available in the PHIS database.

Survey responses were summarized using descriptive statistics. Hospital characteristics across the 3 groups (ICU only, age-based, and weight-based hospitals) were compared using Fisher’s exact test and analysis of variance. Patient outcomes were compared across the 3 groups using multivariable regression analyses, adjusting for race, ethnicity, sex, age, presence of a complex chronic condition, census region, hospital type, and number of beds.17  Number of beds were grouped in 50 bed increments for the purpose of the analysis. For comparisons of patient outcomes, we limited data to 2021 to avoid misclassifying hospitals with recent changes in protocol. Analyses were performed using Stata version 15 (Stata-Corp, College Station, TX, USA).

We received survey responses from 36 of 44 (82%) hospitals (Fig 1). Eight hospitals were excluded from the analysis for missing data, such as dates of protocol adoption or transition, leaving 28 hospitals in our analysis. During the time period studied, there was a steady increase in adoption of non-ICU HFNC protocols, with 71% of responding children’s hospitals reporting non-ICU HFNC protocols in 2021 compared with 11% before 2010 (Fig 2). Weight-based protocols were quite uncommon during the early study period (10% of non-ICU HFNC protocols in 2014), but as of 2021, 75% of non-ICU HFNC protocols are weight-based. The median maximum flow rate for weight-based protocols was 20 L per minute compared with 12 L per minute for age-based protocols (P = .048). Exclusion criteria were specified in 40% of age-based protocols compared with 27% of weight-based protocols (P = .35). Common exclusion criteria are chronic disease, comorbid acute disease, and prematurity.

FIGURE 1

Flow diagram showing the number of included and excluded hospitals.

FIGURE 1

Flow diagram showing the number of included and excluded hospitals.

Close modal
FIGURE 2

Bar chart displaying the proportions of hospitals who use ICU only, age-based non-ICU and weight-based non-ICU high-flow nasal cannula protocols, by year. “<2010”: survey respondents indicated that HFNC protocols started before 2010.

FIGURE 2

Bar chart displaying the proportions of hospitals who use ICU only, age-based non-ICU and weight-based non-ICU high-flow nasal cannula protocols, by year. “<2010”: survey respondents indicated that HFNC protocols started before 2010.

Close modal

Average daily census was highest at hospitals utilizing age-based HFNC protocols. No differences in hospital type (freestanding versus nonfreestanding), mean hospital bed size, nor census region were observed between ICU-only hospitals, age-based hospitals, or weight-based hospitals (Table 1).

TABLE 1

Unadjusted Hospital Characteristics and Adjusted Outcomes in 2021 Comparing Hospitals With HFNC Use in the ICU Only, Those With Age-based non-ICU HFNC Protocols, and Those With Weight-based non-ICU HFNC Protocols

 ICU Only Protocols (n = 8) Age-based Protocols (n = 5) Weight-based Protocols (n = 15) P 
Hospital Characteristics     
 Freestanding 5 (62.5) 4 (80.0) 12 (80.0) .84 
 Hospital size (mean # beds) 369.8 406.8 410.3 .1 
 <200 1 (6.7)  
 200 to <300 3 (20.0)  
 300 to <400 3 (37.5) 2 (40.0) 3 (20.0)  
 400 to <500 2 (25.0) 2 (40.0) 1 (6.7)  
 500 to <600 2 (13.3)  
 600 to <700 2 (13.3)  
 Missing 3 (37.5) 1 (20.0) 3 (20.0)  
 Avg daily census (mean #) 241.0 316.3 289.5 .01 
Geographic region    .96 
 Midwest 4 (50.0) 1 (20) 5 (33.3)  
 Northeast 1 (12.5) 1 (20) 3 (20.0)  
 South 1 (12.5) 2 (40) 4 (26.7)  
 West 1 (12.5) 1 (20) 3 (20.0)  
Patient outcomes by protocol type 
 N = 4934 N = 6584 N = 11 734  
 ICU utilization 1475 (29.9) 2397 (36.4) 2488 (21.2) <.001 
 LOS; median (IQR) 1.9 (1.2–3.3) 2.9 (1.2–4.4) 1.9 (1.2–3.4) <.001 
 NIPPV 168 (3.4) 573 (8.7) 810 (6.9) <.001 
 Mech vent (strict) 64 (1.3) 46 (0.7) 59 (0.5) .01 
 ICU Only Protocols (n = 8) Age-based Protocols (n = 5) Weight-based Protocols (n = 15) P 
Hospital Characteristics     
 Freestanding 5 (62.5) 4 (80.0) 12 (80.0) .84 
 Hospital size (mean # beds) 369.8 406.8 410.3 .1 
 <200 1 (6.7)  
 200 to <300 3 (20.0)  
 300 to <400 3 (37.5) 2 (40.0) 3 (20.0)  
 400 to <500 2 (25.0) 2 (40.0) 1 (6.7)  
 500 to <600 2 (13.3)  
 600 to <700 2 (13.3)  
 Missing 3 (37.5) 1 (20.0) 3 (20.0)  
 Avg daily census (mean #) 241.0 316.3 289.5 .01 
Geographic region    .96 
 Midwest 4 (50.0) 1 (20) 5 (33.3)  
 Northeast 1 (12.5) 1 (20) 3 (20.0)  
 South 1 (12.5) 2 (40) 4 (26.7)  
 West 1 (12.5) 1 (20) 3 (20.0)  
Patient outcomes by protocol type 
 N = 4934 N = 6584 N = 11 734  
 ICU utilization 1475 (29.9) 2397 (36.4) 2488 (21.2) <.001 
 LOS; median (IQR) 1.9 (1.2–3.3) 2.9 (1.2–4.4) 1.9 (1.2–3.4) <.001 
 NIPPV 168 (3.4) 573 (8.7) 810 (6.9) <.001 
 Mech vent (strict) 64 (1.3) 46 (0.7) 59 (0.5) .01 

The proportion of bronchiolitis patients treated in the ICU was highest for age-based hospitals and lowest for weight-based hospitals (36.1% vs 21.0%, respectively, P < .001; Table 1). Additionally, the proportion of bronchiolitis patients treated with NIPPV was highest for age-based hospitals with 11.6% of patients at age-based hospitals receiving NIPPV compared with 6.4% and 3.5% at weight-based and ICU-only hospitals, respectively (P < .001). Length of stay was also significantly longer at age-based hospitals (2.9 days compared with 1.9 days at weight-based and ICU-only hospitals, P < .001). IMV use was most common in ICU-only hospitals with 1.4% of bronchiolitis patients receiving IMV at ICU-only hospitals compared with 0.4% at age-based hospitals and 0.6% at weight-based hospitals (P = .01).

We observed increased adoption of non-ICU based HFNC protocols, especially weight-based protocols. We did not observe differences in most hospital level characteristics between groups. We found decreased use of NIPPV and shorter LOS in weight-based hospitals compared with age-based hospitals. However, NIPPV use was lowest at hospitals using ICU-only HFNC protocols.

We observed a trend toward increasing use of weight-based protocols (75% of non-ICU HFNC protocols in our survey compared with 27% in the 2017 survey by Kalburgi et al).2  The transition to weight-based protocols was also associated with a trend toward allowance of higher maximum flow rates, consistent with flow rates used in recent published randomized control trials.10,11,18 

We identified an association between the use of weight-based protocols and lower ICU utilization, similar to a single center study examining outcomes before and after transition to a weight-based HFNC protocol.5  It is possible that higher flow rates allowed by weight-based HFNC flow protocols, compared with age-based protocols, improve work of breathing and/or provide reassurance to providers considering an escalation of care.19  However, the use of weight-based protocols was associated with increased use of NIPPV compared with ICU-only protocols. One hypothesis for this finding is that once a respiratory escalation has occurred, subsequent respiratory escalations are more likely to occur. The differences in outcomes we observed between age-based protocols and weight-based protocols could also be related to the make-up of protocols, such as restriction of use to bronchiolitis, inclusion of ICU transfer criteria, or protocol exclusion criteria.

Our study has several important limitations. The generalizability of our findings beyond the children’s hospitals that make up PHIS is unclear. Although our response rate was very good (over 80%), there may be differences in hospitals that responded compared with those that did not. Additionally, only 78% of responding hospitals were included in the final analysis because of missing data. This left a smaller number in the age-based protocol group, which means that a single hospital could have greater influence in this group. There may also be hospital-level differences in application of each type of protocol, which we could not account for, as well as differences created by the atypical timing of the 2021 respiratory surge. Although we adjusted for hospital and patient-level covariates in comparing outcomes, other confounders may exist.

Most children’s hospitals have adopted non-ICU HFNC protocols, the majority of which are now utilizing weight-based flow rates. Weight-based protocols were associated with decreased ICU utilization as compared with age-based protocols.

FUNDING: No funding was secured for this study. Dr Coon is the recipient of an Intermountain-Stanford Collaboration Grant (NCT03354325). Dr Tyler is the recipient of a K08 Grant (HS026512) through Agency for Healthcare Research and Quality.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

Drs Willer and Coon conducted data analysis; and all authors conceptualized and designed the study, interpreted data, reviewed and revised the manuscript, and approved the final manuscript as submitted.

1.
Kline
J
,
Kalburgi
S
,
Halley
T
.
High flow nasal cannula therapy for bronchiolitis across the emergency department and acute care floor
.
Clin Pediatr Emerg Med
.
2018
;
19
(
1
):
40
45
2.
Kalburgi
S
,
Halley
T
.
High-flow nasal cannula use outside of the ICU setting
.
Pediatrics
.
2020
;
146
(
5
):
e20194083
3.
Lo
H
,
Moore
RH
,
Rodkey
T
, et al
.
High-flow nasal cannula utilization rates and outcomes in bronchiolitis patients
.
Pediatrics
.
2019
;
144
(
2 MeetingAbstract
):
482
4.
Slain
KN
,
Shein
SL
,
Rotta
AT
.
The use of high-flow nasal cannula in the pediatric emergency department
.
J Pediatr (Rio J)
.
2017
;
93
(
Suppl 1
):
36
45
5.
Willer
RJ
,
Johnson
MD
,
Cipriano
FA
, et al
.
Implementation of a weight-based high-flow nasal cannula protocol for children with bronchiolitis
.
Hosp Pediatr
.
2021
;
11
(
8
):
891
895
6.
Charvat
C
,
Jain
S
,
Orenstein
EW
,
Miller
L
,
Edmond
M
,
Sanders
R
.
Quality initiative to reduce high-flow nasal cannula duration and length of stay in bronchiolitis
.
Hosp Pediatr
.
2021
;
11
(
4
):
309
318
7.
Lipshaw
MJ
,
Vukovic
AA
,
Dean
P
, et al
.
High-flow nasal cannula in bronchiolitis at a pediatric emergency department: trends and outcomes
.
Hosp Pediatr
.
2021
;
11
(
2
):
119
125
8.
Riese
J
,
Porter
T
,
Fierce
J
,
Riese
A
,
Richardson
T
,
Alverson
BK
.
Clinical outcomes of bronchiolitis after implementation of a general ward high flow nasal cannula guideline
.
Hosp Pediatr
.
2017
;
7
(
4
):
197
203
9.
Coon
ER
,
Stoddard
G
,
Brady
PW
.
Intensive care unit utilization after adoption of a ward-based high-flow nasal cannula protocol
.
J Hosp Med
.
2020
;
15
(
6
):
325
330
10.
Kepreotes
E
,
Whitehead
B
,
Attia
J
, et al
.
High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial
.
Lancet
.
2017
;
389
(
10072
):
930
939
11.
Durand
P
,
Guiddir
T
,
Kyheng
C
, et al
;
Bronchopti study group
.
A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis
.
Eur Respir J
.
2020
;
56
(
1
):
1901926
12.
American Academy of Pediatrics
.
VIP network
.
Available at: http://quiin.aap.org. Accessed September 30, 2022
13.
Willer
RJ
,
Coon
ER
,
Harrison
WN
,
Ralston
SL
.
Trends in hospital costs and levels of services provided for children with bronchiolitis treated in children’s hospitals
.
JAMA Netw Open
.
2021
;
4
(
10
):
e2129920
14.
Fujiogi
M
,
Goto
T
,
Yasunaga
H
, et al
.
Trends in bronchiolitis hospitalizations in the United States: 2000-2016
.
Pediatrics
.
2019
;
144
(
6
):
e20192614
15.
Good
RJ
,
Leroue
MK
,
Czaja
AS
.
Accuracy of administrative codes for distinguishing positive pressure ventilation from high-flow nasal cannula
.
Hosp Pediatr
.
2018
;
8
(
7
):
426
429
16.
Shein
SL
,
Slain
K
,
Wilson-Costello
D
,
McKee
B
,
Rotta
AT
.
Temporal changes in prescription of neuropharmacologic drugs and utilization of resources related to neurologic morbidity in mechanically ventilated children with bronchiolitis
.
Pediatr Crit Care Med
.
2017
;
18
(
12
):
e606
e614
17.
Feudtner
C
,
Feinstein
JA
,
Zhong
W
,
Hall
M
,
Dai
D
.
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
.
BMC Pediatr
.
2014
;
14
(
1
):
199
18.
Franklin
D
,
Babl
FE
,
Schlapbach
LJ
, et al
.
A randomized trial of high-flow oxygen therapy in infants with bronchiolitis
.
N Engl J Med
.
2018
;
378
(
12
):
1121
1131
19.
Weiler
T
,
Kamerkar
A
,
Hotz
J
, et al
.
The relationship between high flow nasal cannula flow rate and effort of breathing in children
.
J Pediatr
.
2017
;
189
:
66
71.e3